These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 19756990)

  • 1. Activation profile of intracellular mitogen-activated protein kinases in peripheral lymphocytes of patients with systemic lupus erythematosus.
    Wong CK; Wong PT; Tam LS; Li EK; Chen DP; Lam CW
    J Clin Immunol; 2009 Nov; 29(6):738-46. PubMed ID: 19756990
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intracellular JNK, p38 MAPK and NF-kappaB regulate IL-25 induced release of cytokines and chemokines from costimulated T helper lymphocytes.
    Wong CK; Li PW; Lam CW
    Immunol Lett; 2007 Oct; 112(2):82-91. PubMed ID: 17719653
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of mitogen-activated protein kinases in Thy-1-induced T-lymphocyte activation.
    Conrad DM; Furlong SJ; Doucette CD; Boudreau RT; Hoskin DW
    Cell Signal; 2009 Aug; 21(8):1298-307. PubMed ID: 19324083
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation profile of Toll-like receptors of peripheral blood lymphocytes in patients with systemic lupus erythematosus.
    Wong CK; Wong PT; Tam LS; Li EK; Chen DP; Lam CW
    Clin Exp Immunol; 2010 Jan; 159(1):11-22. PubMed ID: 19843090
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oestrogen up-regulates interleukin-21 production by CD4(+) T lymphocytes in patients with systemic lupus erythematosus.
    Lee J; Shin EK; Lee SY; Her YM; Park MK; Kwok SK; Ju JH; Park KS; Kim HY; Cho ML; Park SH
    Immunology; 2014 Aug; 142(4):573-80. PubMed ID: 24495300
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cell-specific activation profile of extracellular signal-regulated kinase 1/2, Jun N-terminal kinase, and p38 mitogen-activated protein kinases in asthmatic airways.
    Liu W; Liang Q; Balzar S; Wenzel S; Gorska M; Alam R
    J Allergy Clin Immunol; 2008 Apr; 121(4):893-902.e2. PubMed ID: 18395552
    [TBL] [Abstract][Full Text] [Related]  

  • 7. BAFF-R and TACI expression on CD3+ T cells: Interplay among BAFF, APRIL and T helper cytokines profile in systemic lupus erythematosus.
    Salazar-Camarena DC; Ortíz-Lazareno P; Marín-Rosales M; Cruz A; Muñoz-Valle F; Tapia-Llanos R; Orozco-Barocio G; Machado-Contreras R; Palafox-Sánchez CA
    Cytokine; 2019 Feb; 114():115-127. PubMed ID: 30467093
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aberrant activation profile of cytokines and mitogen-activated protein kinases in type 2 diabetic patients with nephropathy.
    Wong CK; Ho AW; Tong PC; Yeung CY; Kong AP; Lun SW; Chan JC; Lam CW
    Clin Exp Immunol; 2007 Jul; 149(1):123-31. PubMed ID: 17425653
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD8+iTregs attenuate glomerular endothelial cell injury in lupus-prone mice through blocking the activation of p38 MAPK and NF-κB.
    Liu Y; Deng W; Meng Q; Qiu X; Sun D; Dai C
    Mol Immunol; 2018 Nov; 103():133-143. PubMed ID: 30268079
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypercytokinemia and hyperactivation of phospho-p38 mitogen-activated protein kinase in severe human influenza A virus infection.
    Lee N; Wong CK; Chan PK; Lun SW; Lui G; Wong B; Hui DS; Lam CW; Cockram CS; Choi KW; Yeung AC; Tang JW; Sung JJ
    Clin Infect Dis; 2007 Sep; 45(6):723-31. PubMed ID: 17712756
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhancement of cytokine production and AP-1 transcriptional activity in T cells by thalidomide-related immunomodulatory drugs.
    Schafer PH; Gandhi AK; Loveland MA; Chen RS; Man HW; Schnetkamp PP; Wolbring G; Govinda S; Corral LG; Payvandi F; Muller GW; Stirling DI
    J Pharmacol Exp Ther; 2003 Jun; 305(3):1222-32. PubMed ID: 12649301
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mitogen-activated protein kinase expression and activation does not differentiate benign from malignant mesothelial cells.
    Vintman L; Nielsen S; Berner A; Reich R; Davidson B
    Cancer; 2005 Jun; 103(11):2427-33. PubMed ID: 15830375
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interleukin (IL)-4 and IL-13 up-regulate monocyte chemoattractant protein-1 expression in human bronchial epithelial cells: involvement of p38 mitogen-activated protein kinase, extracellular signal-regulated kinase 1/2 and Janus kinase-2 but not c-Jun NH2-terminal kinase 1/2 signalling pathways.
    Ip WK; Wong CK; Lam CW
    Clin Exp Immunol; 2006 Jul; 145(1):162-72. PubMed ID: 16792687
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Defects of mitogen-activated protein kinase in ICOS signaling pathway lead to CD4(+) and CD8(+) T-cell dysfunction in patients with active SLE.
    Gang C; Jiahui Y; Huaizhou W; Qing C; Dongbao Z; Qian S
    Cell Immunol; 2009; 258(1):83-9. PubMed ID: 19376499
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathogenic T cells in murine lupus exhibit spontaneous signaling activity through phosphatidylinositol 3-kinase and mitogen-activated protein kinase pathways.
    Niculescu F; Nguyen P; Niculescu T; Rus H; Rus V; Via CS
    Arthritis Rheum; 2003 Apr; 48(4):1071-9. PubMed ID: 12687551
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aberrant expression of regulatory cytokine IL-35 in patients with systemic lupus erythematosus.
    Cai Z; Wong CK; Kam NW; Dong J; Jiao D; Chu M; Lam CW; Tam LS
    Lupus; 2015 Oct; 24(12):1257-66. PubMed ID: 25966926
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation, differential localization, and regulation of the stress-activated protein kinases, extracellular signal-regulated kinase, c-JUN N-terminal kinase, and p38 mitogen-activated protein kinase, in synovial tissue and cells in rheumatoid arthritis.
    Schett G; Tohidast-Akrad M; Smolen JS; Schmid BJ; Steiner CW; Bitzan P; Zenz P; Redlich K; Xu Q; Steiner G
    Arthritis Rheum; 2000 Nov; 43(11):2501-12. PubMed ID: 11083274
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elevated production of B cell chemokine CXCL13 is correlated with systemic lupus erythematosus disease activity.
    Wong CK; Wong PT; Tam LS; Li EK; Chen DP; Lam CW
    J Clin Immunol; 2010 Jan; 30(1):45-52. PubMed ID: 19774453
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Do elevated levels of serum-soluble fas contribute to the persistence of activated lymphocytes in systemic lupus erythematosus?
    Bijl M; van Lopik T; Limburg PC; Spronk PE; Jaegers SM; Aarden LA; Smeenk RJ; Kallenberg GG
    J Autoimmun; 1998 Oct; 11(5):457-63. PubMed ID: 9802929
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NF-κB, ERK, p38 MAPK and JNK contribute to the initiation and/or maintenance of mechanical allodynia induced by tumor necrosis factor-alpha in the red nucleus.
    Zhang Q; Wang J; Duan MT; Han SP; Zeng XY; Wang JY
    Brain Res Bull; 2013 Oct; 99():132-9. PubMed ID: 24161765
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.